The Gastrointestinal Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Gastrointestinal Therapeutics Market?
The historical growth trend in the Gastrointestinal Therapeutics Global Market Report 2025 indicates a strong increase from $39.99 billion in 2024 to $42.30 billion in 2025. This represents a compound annual growth rate (CAGR) of 5.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Gastrointestinal Therapeutics Industry?
The Gastrointestinal Therapeutics Global Market Report 2025 predicts that by 2029, the market size will reach $52.41 billion, expanding at a compound annual growth rate (CAGR) of 5.5%.
Download Your Free Sample of the 2025 Gastrointestinal Therapeutics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Gastrointestinal Therapeutics Market?
The key drivers in the gastrointestinal therapeutics market are:
• The increase in inflammatory bowel diseases is expected to stimulate the gastrointestinal therapeutics market.
• Chronic conditions that cause digestive tract inflammation are driving demand for gastrointestinal therapeutics.
• The genetic susceptibility to an abnormal immune response to gut microbes results in more requirement for therapeutics.
• A need to manage and treat bowel diseases, regulating digestive functions, and alleviate associated symptoms is driving growth in this market.
Global Market Segmentation: Identifying Major Gastrointestinal Therapeutics Industry Segments
The gastrointestinal therapeutics market covered in this report is segmented –
1) By Product: Over-The-Counter Gastrointestinal Therapeutics, Prescription-Based Gastrointestinal Therapeutics
2) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration
3) By Application: Inflammatory Bowel Disease, Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Irritable Bowel Syndrome, Other Applications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Other End-Users
Pre-order the 2025 Gastrointestinal Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Gastrointestinal Therapeutics Market?
The key trends in the gastrointestinal therapeutics market are:
• Market players are focusing on developing innovative therapies such as sustained-release (SR) fixed-dose combination capsules.
• Emphasis on improving patient compliance and enhancing treatment effectiveness is rising.
• The adoption of combining different medications for more effective relief from multiple symptoms is an emerging trend.
• The treatment of gastroesophageal reflux disease, peptic ulcers, and other related GI conditions are greatly influenced by these new therapies.
Who Are the Top Competitors & Leading Players in the Gastrointestinal Therapeutics Market?
Major players in the gastrointestinal therapeutics market are:
• Abbott Laboratories
• Novartis AG
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim International GmbH
• Otsuka Holdings Co. Ltd.
• Daiichi Sankyo Company Limited
• Bausch Health Companies Inc
• Olympus Corporation
• UCB S.A
• Eisai Co. Ltd.
• Aurobindo Pharma Limited
• Dr. Reddy’s Laboratories Limited
• Ironwood Pharmaceuticals Inc
• Salix Pharmaceuticals Ltd
• Ferring Pharmaceuticals A/S
• Jubilant Pharma Limited
• Sebela Pharmaceuticals Inc
• Cosmo Pharmaceuticals N.V
• Tillotts Pharma AG
• Mitsubishi Tanabe Pharma Corporation
Regional Dominance: Which Area Leads the Global Gastrointestinal Therapeutics Market?
North America was the largest region in the gastrointestinal therapeutics market in 2024
